Identification of bazedoxifene for the treatment of LGMD R2 by high throughput screening.
Bruge, C.; Bourg, N.; PELLIER, E.; Tournois, J.; Polentes, J.; BENABIDES, M.; Grossi, N.; Bigot, A.; Brureau, A.; Richard, I.; Nissan, X.
Show abstract
LGMD R2 is a rare genetic disorder characterized by progressive proximal muscle weakness and wasting caused by a recessive loss of function of dysferlin, a transmembrane protein controlling plasma membrane repair in skeletal muscles. We report here the development of an in vitro high-throughput assay using immortalized myoblasts and monitored reallocation of an aggregated mutant form of dysferlin (DYSFL1341P). Using this assay, we screened a library of 2239 drugs and identified two autophagy inducers, namely saracatinib and bazedoxifene, as potential drugs to repurpose for LGMD R2 patients carrying the DYSFL1341P mutation. Functional characterization of these drugs revealed that saracatinib and bazedoxifene had a protective effect on the plasma membrane in osmotic shock assay. While saracatinib restores functionality in membrane resealing through a specific rescue of L1341P dysferlin from degradation, bazedoxifene demonstrates an additional protective effect on dysferlin KO mice muscle fibers. Finally, further investigations into the molecular mechanism of action of bazedoxifene revealed an induction of autophagy flux, which may underlie the molecules effect on the survival of LGMD R2 myofibers.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Identification of novel autophagy inducers by accelerating lysosomal clustering against Parkinson's disease 94%
- Improvement of muscle strength in a mouse model for congenital myopathy treated with HDAC and DNA methyltransferase inhibitors 94%
- Pharmacological rescue of impaired mitophagy in Parkinson's disease-related LRRK2 G2019S knock-in mice 94%
Similar papers in this journal
- The ion channel TRPM8 is a direct target of the immunosuppressant rapamycin in primary sensory neurons 91%
- Differences in signalling, trafficking and glucoregulatory properties of glucagon-like peptide-1 receptor agonists exendin-4 and lixisenatide 91%
- Cross-pathway integration of cAMP signals through cGMP and calcium-regulated phosphodiesterases in mouse striatal cholinergic interneurons. 90%
Similar papers in this journal
- A novel class of allosteric glucosylceramidase beta 1 correctors that reduce cellular stress and enhance lysosomal function 94%
- Lamin-related congenital muscular dystrophy alters mechanical signaling and skeletal muscle growth 92%
- Differential Dynamics and Roles of FKBP51 Isoforms and Their Implications for Targeted Therapies 92%
Similar papers in this journal
- PINK1 Deficiency Alters Muscle Stem Cell Fate Decision And Muscle Regenerative Capacity. 94%
- Modulation of the JAK2-STAT3 pathway promotes expansion and maturation of human iPSCs-derived myogenic progenitor cells 93%
- Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m.3243A > G heteroplasmy in iPSC-derived neurons 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.